United States

Northwest Biotherapeutics Inc (NWBO.OQ)

NWBO.OQ on NASDAQ Stock Exchange Capital Market

5 Dec 2016
Change (% chg)

$0.02 (+3.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Linda Powers

59 2012 Chairperson of the Board, President, Chief Executive Officer

Leslie Goldman

70 2011 Senior Vice President - Business Development

Anthony Maida

61 2013 Senior Vice President - Clinical Research

Marnix Bosch

55 2011 Chief Technical Officer

Alton Boynton

71 2012 Chief Scientific Officer, Director